Evaluating the Abuse Potential of Lenabasum, a Selective CB2 Cannabinoid Receptor Agonist

Luba, R., Madera, G., Schusterman, R., Kolodziej, A., Hodgson, I., & Comer, S. D. (2024). Evaluating the Abuse Potential of Lenabasum, a Selective CB2 Cannabinoid Receptor Agonist. Journal of Pharmacology and Experimental Therapeutics, JPET-AR-2024-002129. https://doi.org/10.1124/jpet.124.002129
Authors:
Rachel Luba
Gabriela Madera
Rebecca Schusterman
Andrew Kolodziej
Ian Hodgson
Sandra D. Comer
Affiliated Authors:
Rachel Luba
Sandra D. Comer
Columbia Affiliation:
Subjects:
Endocannabinoid System and Its Effects on Health (OpenAlex Topic)
Forensic Toxicology Methods and Analysis (OpenAlex Topic)
Role of Sigma Receptors in Cellular Signaling (OpenAlex Topic)
Author Keywords:
cannabinoid
cannabinoid receptors
human/clinical
elink
Publication Type:
Article
Unique ID:
10.1124/jpet.124.002129
PMID:
38936978
DOI:
10.1124/jpet.124.002129
Journal:
Journal of Pharmacology and Experimental Therapeutics
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: